跳至主要内容
临床试验/ITMCTR2024000034
ITMCTR2024000034已完成1 期

A randomized controlled study on the treatment of severe acute pancreatitis with intraperitoneal hypertension through nasogastric nutrition tube administration of Gansui

Guangdong Provincial Hospital of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • (1) Meets the diagnostic criteria for moderate severe acute pancreatitis or severe acute pancreatitis (refer to the 2021 edition of Chinese Guidelines for Diagnosis and Treatment of Acute Pancreatitis);
  • (2) Gansui can be administered through a nasojejacual nutrition tube;
  • (3) Voluntarily participate in this study and sign an informed consent form;
  • (4) Age = 18 and = 75 years old, regardless of gender.

排除标准

  • (1) No gastrointestinal administration route;
  • (2) Have a history of major digestive surgery in the past;
  • (3) Patients who are currently participating in or have participated in other clinical trials within the month prior to this study;
  • (4) Allergic reactions to therapeutic drugs;
  • (5) Patients with fertility requirements or those who are pregnant or breastfeeding;
  • (6) Liver function: Child Pugh C-grade;
  • (7) Kidney function: CKD stage 4 or 5.

研究者

发起方
Guangdong Provincial Hospital of Chinese Medicine

相似试验